BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

Andere talen Biohaven Pharmaceutical Holding Company Ltd.

Aandelen

BHVN

VGG111961055

Beurs gesloten - Nyse Andere beurzen 22:00:01 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
38,72 ^USD	-2,25%		-12,06%	-74,49%

23/04	Aandelen Biohaven stijgen na afsluiting openbaar aanbod, openbaarmaking aankoop aandelen door CEO	MT
23/04	BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. : UBS bevestigt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO	23/04
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares	23/04
Biohaven Insider Bought Shares Worth $7,999,961, According to a Recent SEC Filing	23/04
Biohaven Insider Bought Shares Worth $4,999,991, According to a Recent SEC Filing	23/04
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares	19/04
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	18/04
Biohaven Prices $230 Million Public Share Offering	18/04
Biohaven Launches $200 Million Common Stock Offering	17/04
Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology Annual Meeting and Provides Other Business Updates	15/04
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments	01/03
Biohaven Q4 Non-GAAP Net Loss Widens, Shares Fall After-Hours	29/02
Biohaven Highlights Progress across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference	09/01
Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
Biohaven Insider Sold Shares Worth $459,663, According to a Recent SEC Filing	02/01
Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting	04/12
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments	15/11
Biohaven Pharmaceutical Q3 Net Loss Narrows	14/11
Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society's Annual Meeting, ObesityWeek	17-10-23
Biohaven Pharmaceutical Says Obesity Treatment Candidate Reduces Fat, Improves Lean Mass	16-10-23
Biohaven Insider Bought Shares Worth $9,999,990, According to a Recent SEC Filing	11-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biohaven Pharmaceutical Holding Company Ltd.

Aandelen

BHVN

VGG111961055

Andere talen

Filters